KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 142 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $230,000 | -74.6% | 61,177 | -58.5% | 0.01% | -78.6% |
| Q1 2017 | $907,000 | +398.4% | 147,400 | +328.5% | 0.04% | -28.8% |
| Q3 2016 | $182,000 | -61.4% | 34,400 | -51.7% | 0.06% | +156.5% |
| Q2 2016 | $471,000 | -88.1% | 71,254 | -82.0% | 0.02% | -82.6% |
| Q2 2015 | $3,951,000 | +77.6% | 395,913 | +151.7% | 0.13% | +59.0% |
| Q4 2014 | $2,225,000 | -49.7% | 157,314 | -39.4% | 0.08% | -64.5% |
| Q1 2014 | $4,420,000 | +288.4% | 259,439 | +195.0% | 0.23% | +290.0% |
| Q4 2013 | $1,138,000 | -39.5% | 87,951 | -52.8% | 0.06% | -41.7% |
| Q3 2013 | $1,880,000 | +72.6% | 186,349 | +27.7% | 0.10% | +186.1% |
| Q2 2013 | $1,089,000 | – | 145,898 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Old West Investment Management, LLC | 1,068,719 | $3,633,000 | 1.50% |
| Abrams Capital Management | 9,108,867 | $30,970,000 | 0.82% |
| Baupost Group | 25,791,678 | $87,692,000 | 0.67% |
| Bristol Advisors, LLC | 51,100 | $174,000 | 0.29% |
| RICE HALL JAMES & ASSOCIATES, LLC | 2,228,059 | $7,575,000 | 0.27% |
| NEXTHERA CAPITAL LP | 200,000 | $680,000 | 0.13% |
| LINCOLN CAPITAL CORP | 37,280 | $127,000 | 0.10% |
| Meridian Wealth Management, LLC | 49,600 | $169,000 | 0.07% |
| Rubric Capital Management LP | 199,883 | $680,000 | 0.07% |
| Virtus ETF Advisers LLC | 155,009 | $527,000 | 0.05% |